3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
6
Lymphoma
3
Lung Neoplasms
3
Carcinoma, Hepatocellular
3
Squamous Cell Carcinoma of Head and Neck
2
Small Cell Lung Carcinoma
2
Rectal Neoplasms
2
Melanoma
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Head and Neck Neoplasms
2
Gastrointestinal Neoplasms
2
Colonic Neoplasms
2
Burkitt Lymphoma
2
Breast Neoplasms
2
Vasculitis
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Smoking Cessation
1
Recurrence
1
Pancreatic Neoplasms
1
Osteomyelitis
1
Nose Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Pulmonary Nodules
1
Metastatic Solid Tumors
1
Lymphoproliferative Disorders
1
Interventions
Paclitaxel
96
Carboplatin
81
Bevacizumab
62
Gemcitabine
36
liposomal doxorubicin
32
pembrolizumab
30
Topotecan
26
olaparib
23
Taxes
23
niraparib
17
Immunoglobulin G
17
Disulfides
17
Docetaxel
16
Cyclophosphamide
16
Cisplatin
14
Nivolumab
11
rucaparib
10
durvalumab
10
Doxorubicin
9
Albumin-Bound Paclitaxel
8
sargramostim
7
pazopanib
7
fludarabine phosphate
7
fludarabine
7
avelumab
7
Magnetic Resonance Spectroscopy
7
Ifosfamide
7
epacadostat
6
Trabectedin
6
Sorafenib
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Ovarian Neoplasms
×
Tomography, X-Ray Computed
×
Clear all
No trials found.